Form HCA13-0060 Lutetium Lu 177 Dotate (Lutathera) Authorization Request - Washington

What Is Form HCA13-0060?

This is a legal form that was released by the Washington State Health Care Authority - a government authority operating within Washington. As of today, no separate filing guidelines for the form are provided by the issuing department.

FAQ

Q: What is Form HCA13-0060?
A: Form HCA13-0060 is an authorization request form for Lutetium Lu 177 Dotate (Lutathera) in the state of Washington.

Q: What is Lutetium Lu 177 Dotate (Lutathera)?
A: Lutetium Lu 177 Dotate (Lutathera) is a medication used for the treatment of certain types of cancer.

Q: Who can request authorization for Lutetium Lu 177 Dotate (Lutathera)?
A: Healthcare providers can request authorization for Lutetium Lu 177 Dotate (Lutathera) on behalf of their patients.

Q: What is the purpose of this authorization request?
A: The purpose of this authorization request is to obtain approval for the use of Lutetium Lu 177 Dotate (Lutathera) for a specific patient.

Q: Is this authorization request specific to the state of Washington?
A: Yes, this authorization request is specific to the state of Washington.

Q: How can healthcare providers obtain Form HCA13-0060?
A: Healthcare providers can obtain Form HCA13-0060 by contacting the appropriate authority in the state of Washington.

Q: Are there any eligibility criteria for Lutetium Lu 177 Dotate (Lutathera) authorization?
A: Yes, there may be eligibility criteria for Lutetium Lu 177 Dotate (Lutathera) authorization, which can vary depending on the specific guidelines in Washington.

Q: What should healthcare providers do if they have questions about the authorization process?
A: Healthcare providers should reach out to the appropriate authority in Washington for any questions regarding the authorization process.